PL405774A1 - Method for detecting of high genetically conditioned risk of the prostatic carcinoma - Google Patents
Method for detecting of high genetically conditioned risk of the prostatic carcinomaInfo
- Publication number
- PL405774A1 PL405774A1 PL40577413A PL40577413A PL405774A1 PL 405774 A1 PL405774 A1 PL 405774A1 PL 40577413 A PL40577413 A PL 40577413A PL 40577413 A PL40577413 A PL 40577413A PL 405774 A1 PL405774 A1 PL 405774A1
- Authority
- PL
- Poland
- Prior art keywords
- mutation
- gene
- chek2
- detecting
- risk
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000001143 conditioned effect Effects 0.000 title 1
- 230000035772 mutation Effects 0.000 abstract 6
- 101150064168 CHEK2 gene Proteins 0.000 abstract 4
- 101100220617 Homo sapiens CHEK2 gene Proteins 0.000 abstract 4
- 108700028369 Alleles Proteins 0.000 abstract 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 abstract 1
- 101100178941 Homo sapiens HOXB13 gene Proteins 0.000 abstract 1
- 101150016316 NBS1 gene Proteins 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 239000012620 biological material Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 102200145956 rs138213197 Human genes 0.000 abstract 1
- 102210018811 rs188140481 Human genes 0.000 abstract 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Wynalazek ujawnia sposoby i produkty znajdujące zastosowanie w diagnozowaniu genetycznej predyspozycji do chorób u ludzi i polega na ocenie czy w materiale biologicznym badanej osoby występuje specyficzna zmiana z panelu siedmiu zmian DNA w tym: 1) mutacja 657del5 genu NBS1; 2) mutacja IVS2+1G>A genu CHEK2; 3) mutacja del5395 genu CHEK2; 4) mutacja 1100delC genu CHEK2; 5) mutacja Il157T genu CHEK2; 6) mutacja G84E genu HOXB13; 7) allel A zmiany rs188140481 w regionie 8q24. Wynalazek dotyczy również nowej metody diagnostycznej wykrywającej wysokie ryzyko raka prostaty u mężczyzn w polskiej populacji.The invention discloses methods and products used in the diagnosis of genetic predisposition to human diseases and consists in assessing whether the biological material of the examined person has a specific change from a panel of seven DNA changes including: 1) mutation 657del5 of the NBS1 gene; 2) IVS2 + 1G> A mutation of the CHEK2 gene; 3) del5395 mutation of the CHEK2 gene; 4) mutation 1100delC of the CHEK2 gene; 5) mutation Il157T of the CHEK2 gene; 6) G84E mutation of the HOXB13 gene; 7) allele A rs188140481 change in region 8q24. The invention also relates to a new diagnostic method detecting the high risk of prostate cancer in men in the Polish population.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL405774A PL236138B1 (en) | 2013-10-26 | 2013-10-26 | Method for detecting of high genetically conditioned risk of the prostatic carcinoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL405774A PL236138B1 (en) | 2013-10-26 | 2013-10-26 | Method for detecting of high genetically conditioned risk of the prostatic carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL405774A1 true PL405774A1 (en) | 2015-04-27 |
| PL236138B1 PL236138B1 (en) | 2020-12-14 |
Family
ID=52987886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL405774A PL236138B1 (en) | 2013-10-26 | 2013-10-26 | Method for detecting of high genetically conditioned risk of the prostatic carcinoma |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL236138B1 (en) |
-
2013
- 2013-10-26 PL PL405774A patent/PL236138B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL236138B1 (en) | 2020-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yates et al. | The European society for medical oncology (ESMO) precision medicine glossary | |
| Saykin et al. | Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans | |
| Terranova et al. | Polycomb group proteins Ezh2 and Rnf2 direct genomic contraction and imprinted repression in early mouse embryos | |
| EP4484572A3 (en) | Identification and use of circulating nucleic acid tumor markers | |
| MX2009012722A (en) | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment. | |
| EP2663656A1 (en) | Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment | |
| MX392267B (en) | METHODS FOR EVALUATING THE RISK OF DEVELOPING BREAST CANCER. | |
| WO2013153458A3 (en) | Method for the prognosis and treatment of cancer metastasis | |
| HRP20191182T1 (en) | Identification of tumor-protective epitopes for the treatment of cancers | |
| WO2009009752A3 (en) | Genetic models for stratification of cancer risk | |
| WO2011153545A3 (en) | Gene expression signature as a predictor of chemotherapeutic response in breast cancer | |
| HK1197085A1 (en) | Genetic variants for predicting risk of breast cancer | |
| Gandolfi et al. | The extent of whole‐genome copy number alterations predicts aggressive features in primary melanomas | |
| Abreu et al. | Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia | |
| Nissar et al. | XRCC3 Thr241Met gene polymorphism and risk of colorectal cancer in Kashmir: a case control study | |
| Emmert et al. | Do not underestimate nucleotide excision repair: it predicts not only melanoma risk but also survival outcome | |
| BRPI0608429A2 (en) | method and kit for predicting or evaluating the effectiveness of treating a solid tumor in a patient of interest; and method for identifying markers that are prognostic for a solid tumor | |
| CY1115258T1 (en) | METHODS AND USES INCLUDING NAV3 GENETIC DERIVATIVES AND DIFFERENT MULTIPLE GENE EXPRESSION | |
| Ahmad et al. | Prognostic effect of vascular endothelial growth factor+ 936C/T polymorphism on tumor growth pattern and survival in patients diagnosed with colon carcinoma | |
| Kumar et al. | Multimodal genomic markers predict immunotherapy response in the head and neck squamous cell carcinoma | |
| PL401271A1 (en) | Method and kit for the detection of aggressive prostate cancer with poor prognosis | |
| Yao et al. | 140 AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma | |
| PL410186A1 (en) | Method, application and a set for detecting high risk breast cancer with bad prognosis | |
| Obe et al. | Cancer risk evaluation: methods and trends | |
| Kim et al. | 143 Identification of actinic keratosis susceptibility loci |